Insights

Reimagining the future

Life Science

Do you trust your software? Why you should seriously consider using Rust in your next diagnostic and medical device

Read post

Edge Image Processing: Development of a Robust Sensor Platform for Bore-Hole Detection on Autonomous Ground Vehicles in Open-Pit Mines

The long game: how strategic thinking prevents medical device development failure

Using AI foundation models to unlock the full potential of digital twins

Life Science

All posts Healthcare Deep Tech Life Science

UTI Diagnostics: An opportunity to improve antimicrobial stewardship and women’s health

Do you trust your software? Why you should seriously consider using Rust in your next diagnostic and medical device

Plug and play genomics for next-gen therapies

Distributing diagnostics: locations, motivations, metrics

Cell and Gene Therapy

Non-contact cell counting enables in-line, real-time monitoring of manufacturing processes

Cell and Gene Therapy

Treatment of chronic conditions is the new frontier for stem cell-derived therapies: Deep phenotyping and manufacturing scale-up key to opening clinic doors, say experts at TTP’s panel discussion

In the Hot Seat: Challenging Conventions in Precision Medicine

mrna personalised cancer vaccine cell render

Personalised mRNA therapies are coming and will challenge established analytical technologies: Should we look to the diagnostics sector for improved Quality Control?

using omics to quality control cell and gene therapy

Omics: Unlocking a New Era of Quality Control and Treatment Insight for Cell and Gene Therapy

A Greener Future of Discovery with More Powerful Drug Screens

cancer cells being attacked by T Cells

Cell and Gene Therapy

With personalised cancer vaccines on the rise, is manufacturing scalable yet?

Protein DNA

Multi-omics: When Worlds Collide, Opportunities Arise

diagnostic test

Seven ideas to reduce the environmental impact of point-of-care diagnostics

A new era in point-of-care diagnostic testing: possibilities and practicalities

woman in lab carrying out library prep

Shape Up, Library Prep: Innovating for Efficient, Low Cost and Sustainable Workflows

eDNA with a city background

Environmental DNA and RNA: versatile tools with huge untapped commercial potential

Diagnostics: areas of growth, change, and wider interest that could transform the industry

How is cell and gene therapy innovation adapting to a changing investment landscape? Insights from TTP’s Cell & Gene panel event

Are we entering a new era in point-of-care diagnostic testing?

How can you prove 99.9% reliability? A challenge in automating and scaling cell therapies

Spatial biology: FISH and sequencing reveal gene expression patterns. Where is the industry now, and what will the future bring?

Translating spatial biology into tissue diagnostics with inventive technology

Next-generation sample preparation: Will better nucleic acid extraction unleash biotechnology, life sciences and diagnostics?

As we predicted: Isothermal amplification diagnostics shoot to prominence in point-of-care market

up close of a chip for manufacturing

Could the “chip shortage” hit your product? Here’s what to do.

Multiplex cytokine measurement: Covid and beyond

The antimicrobial susceptibility testing conundrum

Front-loading monoclonal antibody screening for faster drug discovery

What failure rate are we willing to accept in cell therapy manufacture? Insights from medical device development

Biomimetics evolution at the micron scale and beyond

Special Delivery: can advanced intracellular delivery enable superior cell therapies for solid tumour treatment – and beyond?

Only a ‘click’ away: click chemistry transforms life science applications

DNA Origami: What can we make of it?

Key early-stage microfabrication decisions for life science start-ups and SMEs

Spotlight on upconversion nanoparticles: finding the right chemistry to make life science applications “click”

Imaging by the numbers: quantitative imaging for digital pathology

How to develop microfluidics for commercial products

Could technology help contain the next equine flu epidemic?

New modes of drug action tackle intractable diseases

The future of molecular diagnostics: Will isothermal amplification techniques steal PCR’s crown in the close-to-patient era?

Can we imagine a future of personalised medicine based on the analysis of lipids and carbohydrates?

Driving Cell Therapy Innovation: Applying Key Lessons from the Evolution and Commercialization of Protein-Based Therapies

New dimensions in 3D bioprinting

Navigating the market for “PoC” diagnostic systems

Predicting failure rates in cell therapy manufacturing: is one in a million good enough?

Editing the genomes of superbugs to combat antibiotic resistence

How many cells should a therapeutic cell sorter sort? (Part 3)

MEMS evolution: from Silicon to Polymers

CRISPR-Cas9 – A chink in the armour of the white knight?

Harnessing microbial machinery in the hunt for new antibiotics

Please diagnose early. Time is of the essence for these patients.

Nanomedicine: A golden horizon

Who should lead the charge in cell therapy manufacturing?

Rising to the undruggable target challenge

Load more posts